AURA BIOSCIENCES INC's ticker is and the CUSIP is 05153U107. A total of 35 filers reported holding AURA BIOSCIENCES INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $13,361,620 | +0.9% | 1,767,410 | +4.7% | 0.00% | – |
| Q1 2024 | $13,246,168 | -13.6% | 1,687,410 | -2.5% | 0.00% | – |
| Q4 2023 | $15,331,619 | +65.8% | 1,730,431 | +67.8% | 0.00% | – |
| Q3 2023 | $9,248,913 | -27.2% | 1,031,094 | +0.3% | 0.00% | – |
| Q2 2023 | $12,697,925 | +30.5% | 1,028,172 | -1.9% | 0.00% | – |
| Q1 2023 | $9,730,887 | +7.3% | 1,048,587 | +21.4% | 0.00% | – |
| Q4 2022 | $9,067,591 | -17.4% | 863,580 | +42.5% | 0.00% | – |
| Q3 2022 | $10,978,000 | +78.0% | 605,884 | +39.2% | 0.00% | – |
| Q2 2022 | $6,167,000 | +22.6% | 435,175 | +90.3% | 0.00% | – |
| Q1 2022 | $5,030,000 | +30.9% | 228,633 | +1.0% | 0.00% | – |
| Q4 2021 | $3,842,000 | – | 226,258 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Medicxi Ventures Management (Jersey) Ltd | 3,039,892 | $31,918,866 | 13.40% |
| Regency Capital Management Inc.\DE | 554,286 | $5,820,003 | 6.69% |
| Decheng Capital Management III (Cayman), LLC | 293,333 | $3,079,997 | 1.15% |
| Matrix Capital Management Company, LP | 5,362,870 | $56,310,135 | 1.08% |
| Monashee Investment Management LLC | 131,640 | $1,382,220 | 0.60% |
| Nantahala Capital Management | 798,751 | $8,386,886 | 0.54% |
| Eventide Asset Management | 2,251,368 | $23,639,364 | 0.47% |
| Rock Springs Capital Management LP | 1,019,757 | $10,707,449 | 0.26% |
| Artal Group S.A. | 410,000 | $4,305 | 0.24% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 2,132,739 | $22,393,760 | 0.05% |